AlphAIalphai — Financial news for AI agents
manilatimes.netMAY 286 min read$SOTK

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Sono-Tek (Nasdaq: SOTK) reported FY2026 net sales of $20.9M (+2% YoY), gross margin of 51% (up from 47.5%), operating income of $1.82M (+81%), and net income of about $1.8M (+42%), according to the company. Q4 net sales were $5.6M (+10%). Backlog was $9.1M. The company expects continued 1H FY2027 revenue growth driven by medical and high-ASP systems; FY2027 revenue projected flat to modestly higher.

Original reporting
manilatimes.net
Published May 28, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results — source image
Source · manilatimes.net
Decision brief

The 30-second read

$SOTKBullishMed
01

Why it matters

FY2026 shows broad profitability improvement (51% gross margin; +81% operating income; +42% net income) and a strong backlog ($9.12M). Management expects continued revenue growth and profitability in 1H FY2027 driven by medical demand and high-ASP production systems, while clean-energy electrolysis orders remain uncertain/declining.

02

Market read

Actionable for SOTK traders due to same-day guidance and margin/backlog datapoints that can drive earnings-follow-through and positioning ahead of the call.

03

What to watch

Backlog is strong but still relatively small in absolute dollars; quarterly revenue can swing materially if high-ASP system deliveries are delayed.

Relevance 9/10Novelty 8/10Timing: Conference call scheduled for 10:30 AM ET today (same-day digestion of results/guidance).

Background

Sono-Tek is a developer/manufacturer of ultrasonic coating systems used in medical, electronics, and clean-energy applications. The company released FY2026 financial results and an outlook for 1H FY2027.

Company-level read

Ticker impact

$SOTKBullishMedium confidence
Context

Sono-Tek reported FY2026 results and guided 1H FY2027 growth, citing medical demand and high-ASP systems driving margins and backlog.

Expected impact

Likely positive bias for SOTK around the conference call, with follow-through dependent on how investors weigh medical strength vs. clean-energy softness.

Evidence & confidence

The article provides concrete financial datapoints (revenue, gross margin, operating/net income) and a specific near-term growth outlook, which are typically actionable for small/mid-cap earnings-follow-through; however, full-year visibility is described as limited.

Market effects

Sector

Read-through for ultrasonic coating / medical device manufacturing supply chain: medical and electronics demand appears to be offsetting weaker clean-energy electrolysis orders.

Regional

US margin tailwind highlighted via higher U.S.-based system sales; could influence investor focus on domestic vs. international mix for similar industrial med-tech suppliers.

Global

Clean-energy policy changes are cited as reducing electrolysis-related demand, implying policy-driven volatility for companies tied to that end market.

Counterpoint

What could challenge this read

The company flags uncertainty beyond 1H FY2027 due to timing of high-ASP orders and clean-energy softness; the market may discount the guidance if delivery timing slips.

Key entities

  • company
    Sono-Tek Corporation

    Reported FY2026/Q4 FY2026 results and provided 1H FY2027 growth expectations tied to medical and high-ASP systems.

  • person
    Steve Harshbarger

    CEO & President; attributed margin expansion to product mix and higher U.S. sales, and discussed end-market demand trends.

  • person
    Dr. Christopher L. Coccio

    Executive Chairman; emphasized long profitability streak and backlog as foundation for strategy.

Read at source← All news

Related articles

JUL 8
$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

manilatimes.net4 min
JUL 8
$SOTKMed

SONO TEK CORP (SOTK): Results of Operations and Financial Condition

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

SEC EDGAR 8-K6 min
MAY 28
$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.

finance.yahoo.com6 min
AUG 9
$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

peakoil.com4 min
AUG 9
$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

yahoo.com6 min
AUG 9
$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

yahoo.com5 min